Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Mattias Mandorfer, Juan Carlos García‐Pagán et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 69
Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in ratsDenise van der Graaff, Sven Francque, Jesse S Govaerts et al.|Laboratory Investigation|2018Cited by 47
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Tom Vanden Berghe, Luc Van Nassauw et al.|Cell Death and Differentiation|2024Cited by 36
Unravelling the role of iron-catalysed ferroptotic cell death in non-alcoholic steatohepatitisCédric Peleman, Sven Francque, Luc Van Nassauw et al.|Journal of Hepatology|2023Cited by 0
THU-249 The role of the ferroptosis brake glutathione peroxidase 4 in a preclinical model of metabolic dysfunction-associated steatohepatitisCédric Peleman, Tom Vanden Berghe, Emily Van San et al.|Journal of Hepatology|2024Cited by 0